Product Details
| Product Name: Rifampin | CAS No.: 13292-46-1 |
| Min. Order: 1kg | Purity: 0.99 |
| Supply Ability: 1000kg | Release date: 2025/10/31 |
Rifampin - Product Introduction
Definition
Rifampin is a broad-spectrum antibiotic that belongs to the rifamycin class. It is primarily used to treat bacterial infections, especially those caused by Mycobacterium tuberculosis.
Functions
· Antibacterial: Inhibits bacterial RNA synthesis by binding to RNA polymerase, thereby preventing bacterial growth.
· Broad-Spectrum: Effective against a wide range of bacteria, including those causing tuberculosis and certain other infections.
· Resistance Prevention: Often used in combination with other antibiotics to prevent the development of drug-resistant bacteria.
Applications
· Pharmaceuticals: Primarily used to treat tuberculosis, leprosy, and other infections caused by resistant bacteria.
· Combination Therapy: Commonly used in combination with other anti-TB drugs for the treatment of active tuberculosis and in the treatment of chronic infections.
· Research: Investigated for its potential use in addressing other bacterial infections and resistance mechanisms.
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $45.00/500mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-11-01 | |
| $45.00/500mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-05-01 | |
| $/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $45.00/500mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-27 | |
| $150.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-12-24 | |
| $1.00/1KG |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-20 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-09-29 | |
| $10.00/1KG |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 | |
| $999.00/1kg |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2024-08-13 | |
| $0.00/1kg |
VIP2Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-05-11 |

China